• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

原发性恶性心包间皮瘤多学科治疗的长期生存：一例报告

Long-term survival from multidisciplinary treatment of primary malignant pericardial mesothelioma: A case report.

作者信息

Hai Vu Anh, Chau Nghiem Thi Minh, Hoanh Ho Viet, Van Tri Ha, Pho Dinh Cong, Van Nam Nguyen

机构信息

Oncology Center, Military Hospital 103, Vietnam Military Medical University, Hanoi 10000, Viet Nam.

Department of Cardiology, Heart Institute, 108 Military Central Hospital, Hanoi 100000, Viet Nam.

出版信息

Int J Surg Case Rep. 2024 Dec;125:110615. doi: 10.1016/j.ijscr.2024.110615. Epub 2024 Nov 15.

DOI:10.1016/j.ijscr.2024.110615
PMID:39579634
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11621602/
Abstract

INTRODUCTION AND IMPORTANCE

Primary malignant pericardial mesothelioma is an extremely rare disease with a poor prognosis. Currently, there are no specific guidelines for diagnosis and treatment in Vietnam and international countries for this disease, so treatment experiences from previous clinical cases are very important in the management of this disease.

CASE PRESENTATION

The research team reports a clinical case diagnosed and treated with a combination of surgery and chemotherapy using the Pemetrexed + Carboplatin regimen at the Oncology Center. The patient has survived for an additional 17 months up to the current time.

CLINICAL DISCUSSION

This is an exceptionally rare incident. He survived for a duration of 17 months, which is almost three times longer than the average survival time observed in other documented cases. Additional reports on cases with pericardial mesothelioma are necessary to have a comprehensive understanding of its nature, enabling early identification and appropriate treatment.

CONCLUSION

The patient underwent surgical intervention and received chemotherapy as part of their treatment. The research team emphasizes the importance of a multidisciplinary approach in diagnosing and treating primary malignant pericardial mesothelioma.

摘要

引言与重要性

原发性恶性心包间皮瘤是一种极为罕见的疾病，预后较差。目前，越南及国际上针对该疾病尚无具体的诊断和治疗指南，因此以往临床病例的治疗经验对于该疾病的管理非常重要。

病例介绍

研究团队报告了一例在肿瘤中心采用培美曲塞+卡铂方案联合手术及化疗进行诊断和治疗的临床病例。该患者截至目前已存活17个月。

临床讨论

这是一个极其罕见的病例。他存活了17个月，几乎是其他已记录病例平均存活时间的三倍。需要更多关于心包间皮瘤病例的报告，以便全面了解其性质，实现早期识别和恰当治疗。

结论

该患者接受了手术干预并接受化疗作为治疗的一部分。研究团队强调多学科方法在原发性恶性心包间皮瘤诊断和治疗中的重要性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2e54/11621602/2cc50b3db24d/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2e54/11621602/94261bd73c7a/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2e54/11621602/5831d9f153c8/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2e54/11621602/46703849c519/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2e54/11621602/dd53a6a1692d/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2e54/11621602/2cc50b3db24d/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2e54/11621602/94261bd73c7a/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2e54/11621602/5831d9f153c8/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2e54/11621602/46703849c519/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2e54/11621602/dd53a6a1692d/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2e54/11621602/2cc50b3db24d/gr5.jpg

相似文献

1
Long-term survival from multidisciplinary treatment of primary malignant pericardial mesothelioma: A case report.原发性恶性心包间皮瘤多学科治疗的长期生存：一例报告
Int J Surg Case Rep. 2024 Dec;125:110615. doi: 10.1016/j.ijscr.2024.110615. Epub 2024 Nov 15.
2
Primary malignant pericardial mesothelioma presenting with cardiac tamponade.以心脏压塞为表现的原发性恶性心包间皮瘤。
Int J Surg Case Rep. 2020;73:253-256. doi: 10.1016/j.ijscr.2020.07.054. Epub 2020 Jul 17.
3
Positive response of a primary malignant pericardial mesothelioma to pemetrexed plus cisplatin followed by pemetrexed maintenance chemotherapy: A case report.培美曲塞联合顺铂治疗原发性恶性心包间皮瘤的阳性反应及后续培美曲塞维持化疗：病例报告
Oncol Lett. 2016 Jul;12(1):213-216. doi: 10.3892/ol.2016.4598. Epub 2016 May 17.
4
Case Report: Early diagnosis and bevacizumab-based chemotherapy for primary pericardial mesothelioma: a case with occupational asbestos exposure history.病例报告：原发性心包间皮瘤的早期诊断及基于贝伐单抗的化疗：1例有职业性石棉接触史的病例
Front Cardiovasc Med. 2023 Nov 20;10:1257373. doi: 10.3389/fcvm.2023.1257373. eCollection 2023.
5
A case report of an extremely rare and aggressive tumor: primary malignant pericardial mesothelioma.一例极其罕见且侵袭性强的肿瘤病例报告：原发性恶性心包间皮瘤。
Rare Tumors. 2012 Apr 12;4(2):e21. doi: 10.4081/rt.2012.e21. Epub 2012 Apr 13.
6
Co-existing pericardial and pleural malignant mesothelioma responding well to nedaplatin and pemetrexed: a case report.同时存在的心包和胸膜恶性间皮瘤对奈达铂和培美曲塞反应良好：一例报告
AME Case Rep. 2023 Aug 3;7:32. doi: 10.21037/acr-22-102. eCollection 2023.
7
A Case Report of Primary Pericardial Malignant Mesothelioma Treated with Pemetrexed and Cisplatin.培美曲塞和顺铂治疗原发性心包恶性间皮瘤1例报告
J Korean Med Sci. 2017 Nov;32(11):1879-1884. doi: 10.3346/jkms.2017.32.11.1879.
8
A Rare Case of Primary Malignant Pericardial Mesothelioma Diagnosed with Pericardiotomy.一例通过心包切开术诊断的原发性恶性心包间皮瘤罕见病例。
Heart Surg Forum. 2022 Dec 19;25(6):E840-E842. doi: 10.1532/hsf.5047.
9
Primary malignant pericardial mesothelioma with increased serum mesothelin diagnosed by surgical pericardial resection: A case report.经手术心包切除诊断为血清间皮素升高的原发性恶性心包间皮瘤：一例报告
Mol Clin Oncol. 2016 Nov;5(5):553-556. doi: 10.3892/mco.2016.1019. Epub 2016 Sep 15.
10
Surgical treatment of a primary malignant pericardial mesothelioma: case report.原发性恶性心包间皮瘤的外科治疗：病例报告
Acta Chir Belg. 2022 Feb;122(1):48-50. doi: 10.1080/00015458.2020.1736869. Epub 2020 Mar 18.

本文引用的文献

1
The SCARE 2023 guideline: updating consensus Surgical CAse REport (SCARE) guidelines.SCARE 2023 指南：更新共识外科病例报告（SCARE）指南。
Int J Surg. 2023 May 1;109(5):1136-1140. doi: 10.1097/JS9.0000000000000373.
2
Malignant pericardial mesothelioma : A systematic review of current practice.恶性心包间皮瘤：当前实践的系统评价
Herz. 2018 Feb;43(1):61-68. doi: 10.1007/s00059-016-4522-5. Epub 2017 Jan 27.
3
Advances in malignant peritoneal mesothelioma.恶性腹膜间皮瘤的进展
Int J Colorectal Dis. 2015 Jan;30(1):1-10. doi: 10.1007/s00384-014-2029-1. Epub 2014 Oct 21.
4
Three-year survival after surgery for primary malignant pericardial mesothelioma: report of a case.原发性恶性心包间皮瘤术后三年生存率：一例报告。
Surg Today. 2014 May;44(5):948-51. doi: 10.1007/s00595-013-0511-y. Epub 2013 Feb 14.
5
Primary pericardial mesothelioma in a 19-year-old presenting as pericarditis.19 岁患者以心包炎为表现的原发性心包间皮瘤。
Ann Thorac Surg. 2013 Aug;96(2):680-1. doi: 10.1016/j.athoracsur.2013.01.035. Epub 2013 Jan 23.
6
Pericardial mesothelioma and asbestos exposure.心包间皮瘤与石棉暴露。
Int J Hyg Environ Health. 2011 Jun;214(3):276-9. doi: 10.1016/j.ijheh.2010.11.005. Epub 2010 Dec 14.
7
Primary Pericardial Mesothelioma: Report of a Patient and Literature Review.原发性心包间皮瘤：一例患者报告及文献综述
Case Rep Oncol. 2009 Jul 29;2(2):125-132. doi: 10.1159/000228894.
8
Fatal hemopericardial tamponade due to primary pericardial mesothelioma: a case report.原发性心包间皮瘤致心脏压塞致死 1 例报告。
Diagn Pathol. 2009 Dec 9;4:44. doi: 10.1186/1746-1596-4-44.
9
Malignant mesothelioma.恶性间皮瘤
Orphanet J Rare Dis. 2008 Dec 19;3:34. doi: 10.1186/1750-1172-3-34.
10
Primary pericardial mesothelioma.原发性心包间皮瘤
Curr Treat Options Oncol. 2002 Oct;3(5):369-73. doi: 10.1007/s11864-002-0002-7.